Back to search

Article

Pilot assessment of low NK cell-mediated ADCC and<i>FCGR3A</i>genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker

2019-12-27

Abstract excerpt

ADCC (antibody-dependent cell-mediated cytotoxicity) is dependent on the varying capacity of NK cells to kill, the affinities of FCGR3A -encoded CD16A receptors for antibody, and the presence of antigen-specific antibodies. In vivo ADCC depends on the number of CD16A receptor-positive NK cells in blood. We hypothesized that low ADCC cell function or low effector cell numbers could be biomarkers or risk factors for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6de2c3a-fbdf-5b6a-8964-cef83be426c6
DOI
10.1101/2019.12.20.19015438
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pilot assessment of low NK cell-mediated ADCC and<i>FCGR3A</i>genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarkerDOI 10.1101/2019.12.20.19015438
Select a neighboring publication to make it the new centre.